Benefits
Immune system modulation
Cat's claw POAs demonstrate immunomodulatory effects — stimulating phagocytosis, NK cell activity, and lymphocyte proliferation in laboratory and preliminary human studies. Traditional use for recurrent infections and immune deficiency has some mechanistic support, though large clinical trials are lacking.
Rheumatoid arthritis symptom reduction
A small but well-designed RCT (Phase II) showed freeze-dried cat's claw extract significantly reduced swollen joint count and patient-assessed pain vs. placebo in RA patients on standard therapy — with 53% reduction in swollen joints vs. 24% placebo. Larger confirmatory trials needed.
Anti-inflammatory and antioxidant activity
Cat's claw inhibits TNF-α production, NF-κB activation, and COX-2 expression in laboratory studies, and demonstrates antioxidant activity through direct free radical scavenging. These mechanisms support the traditional anti-inflammatory applications in arthritis and infection.
DNA repair support
AC-11® (a water-soluble cat's claw extract) has demonstrated DNA repair-enhancing activity in human cell studies — increasing nucleotide excision repair of UV-induced DNA damage. This novel mechanism has attracted interest for anti-aging and cancer prevention applications.
Mechanism of action
POA immunostimulation vs. TOA immunosuppression
Pentacyclic oxindole alkaloids (POAs) stimulate immune function via macrophage activation and lymphocyte proliferation. Tetracyclic oxindole alkaloids (TOAs) competitively antagonize POA immune-stimulating activity. High-quality POA-standardized extracts (with minimal TOAs) are required for consistent immune benefits — explains the inconsistent results seen with non-standardized products.
NF-κB and TNF-α inhibition
Cat's claw alkaloids and quinovic acid glycosides inhibit NF-κB nuclear translocation and reduce TNF-α production in macrophages and synovial cells — providing the anti-inflammatory mechanism relevant to rheumatoid arthritis and inflammatory conditions.
Nucleotide excision repair pathway enhancement
AC-11® extract enhances the cellular nucleotide excision repair (NER) pathway that removes UV-induced and chemically-damaged DNA bases. This DNA repair mechanism is being studied for applications in cancer chemoprevention and UV skin protection.
Clinical trials
Randomized, double-blind, placebo-controlled phase II trial of freeze-dried Uncaria tomentosa extract (60 mg/day, pentacyclic-oxindole-alkaloid chemotype) vs placebo in 40 patients with active rheumatoid arthritis on sulfasalazine or hydroxychloroquine. 24 weeks. (Mur et al. 2002, J Rheumatol)
40 RA patients on standard DMARDs. 24-week intervention.
Cat's claw group showed significantly reduced number of painful and swollen joints vs placebo (53% vs 24% reduction in painful joints). Patient-assessed pain improved. Mechanism via NF-κB inhibition by pentacyclic oxindole alkaloids (POAs). Note: small phase II trial — has not been followed by larger phase III confirmation. Important: tetracyclic oxindole alkaloid (TOA) chemotype of cat's claw is functionally DIFFERENT (potentially antagonistic to POA effects) — TOA-free POA-standardized extracts should be specified.